Skip Navigation


eCAM Advance Access originally published online on July 5, 2006
eCAM 2006 3(3):291-292; doi:10.1093/ecam/nel048
This Article
Right arrow Full Text Freely available
Right arrow Full Text (PDF) Freely available
Right arrowOA All Versions of this Article:
3/3/291    most recent
nel048v1
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Cooper, E. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cooper, E. L.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?


© 2006 The Author(s)
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/2.0/uk/) which permits unrestricted non-commerical use, distribution, and reproduction in any medium, provided the original work is properly cited.

Editorial

Regional Strength in CAM

Edwin L. Cooper

Laboratory of Comparative Neuroimmunology, Department of Neurobiology, David Geffen School of Medicine at UCLA, University of California Los Angeles, Los Angeles, California 90095-1763, USA

The first 10% of the full text of this article appears below.

Several years ago, I spent a sabbatical at University of Modena, Italy, living nearby in the famous university town of Bologna. While there, firm roots were established to search for anticancer molecules and new wave antibiotics (1,2). Far from my radar screen was another adventure, now unfolding in Bologna and even for eCAM. Little did I realize that another visit was simmering and taking shape-long before the birth of eCAM and the appointment of a strong group of editorial board members focused around that region of Italy, all professors and or practitioners . . . [Full Text of this Article]

For reprints and all correspondence: Edwin L. Cooper, Ph.D., Sc.D. Distinguished Professor and Founding Editor in Chief, eCAM Laboratory of Comparative Neuroimmunology, Department of Neurobiology, David Geffen School of Medicine at UCLA, University of California, Los Angeles, Los Angeles, California 90095-1763, USA. Tel: +1-310-825-9567; Fax: +1-310-825-2224; E-mail: cooper@mednet.ucla.edu; ecam@mednet.ucla.edu


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Evid Based Complement Alternat MedHome page
S. Salvioli, E. Sikora, E. L. Cooper, and C. Franceschi
Curcumin in Cell Death Processes: A Challenge for CAM of Age-Related Pathologies
Evid. Based Complement. Altern. Med., June 1, 2007; 4(2): 181 - 190.
[Abstract] [Full Text] [PDF]